ATE147262T1 - Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung - Google Patents

Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung

Info

Publication number
ATE147262T1
ATE147262T1 AT92903247T AT92903247T ATE147262T1 AT E147262 T1 ATE147262 T1 AT E147262T1 AT 92903247 T AT92903247 T AT 92903247T AT 92903247 T AT92903247 T AT 92903247T AT E147262 T1 ATE147262 T1 AT E147262T1
Authority
AT
Austria
Prior art keywords
zero
controlled release
release systems
order reaction
solvent
Prior art date
Application number
AT92903247T
Other languages
English (en)
Inventor
Donald R Cowsar
Richard L Dunn
Thomas J Laughlin
Original Assignee
Southern Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Res Inst filed Critical Southern Res Inst
Application granted granted Critical
Publication of ATE147262T1 publication Critical patent/ATE147262T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Moulding By Coating Moulds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92903247T 1988-12-02 1991-05-08 Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung ATE147262T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/279,216 US5085866A (en) 1988-12-02 1988-12-02 Method of producing zero-order controlled-released devices
PCT/US1991/003178 WO1992019283A1 (en) 1988-12-02 1991-05-08 Method of producing zero-order controlled-release devices

Publications (1)

Publication Number Publication Date
ATE147262T1 true ATE147262T1 (de) 1997-01-15

Family

ID=37400868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903247T ATE147262T1 (de) 1988-12-02 1991-05-08 Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung

Country Status (8)

Country Link
US (1) US5085866A (de)
EP (1) EP0583244B1 (de)
JP (1) JPH06507379A (de)
AT (1) ATE147262T1 (de)
DE (1) DE69124115T2 (de)
ES (1) ES2098495T3 (de)
HK (1) HK1006808A1 (de)
WO (1) WO1992019283A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5807407A (en) * 1992-05-04 1998-09-15 Biomet, Inc. Medical implant device and method for making same
US5466530A (en) * 1993-01-21 1995-11-14 England; Garry L. Biocompatible components fabricated from a substantially consolidated stock of material
US5607686A (en) * 1994-11-22 1997-03-04 United States Surgical Corporation Polymeric composition
ES2158611T3 (es) 1996-12-20 2001-09-01 Alza Corp Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion.
CA2270975C (en) 1997-07-02 2003-04-01 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
EP1949890A3 (de) 1999-06-04 2011-05-18 ALZA Corporation Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
WO2001043726A1 (en) * 1999-12-16 2001-06-21 Trident Technologies, Llc System and method for extended delivery of a therapeutic agent with its receptor loading dose
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
CA2466642C (en) * 2001-11-14 2011-01-18 Guohua Chen Injectable depot composition
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
JP2005519873A (ja) * 2001-11-14 2005-07-07 アルザ・コーポレーション カテーテル注入可能なデポー組成物およびそれらの使用
CN1703197A (zh) * 2001-11-14 2005-11-30 阿尔扎有限公司 可注射的长效组合物和其使用
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
TWI353854B (en) 2002-06-25 2011-12-11 Alza Corp Short duration depot formulations
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ES2319400T3 (es) * 2002-07-31 2009-05-07 Durect Corporation Composiciones deposito inyectables y empleo de las mismas.
DK1539101T3 (da) 2002-07-31 2009-04-27 Alza Corp Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
AU2003295409B2 (en) * 2002-11-06 2010-02-11 Durect Corporation Controlled release depot formulations
US20070184084A1 (en) * 2003-05-30 2007-08-09 Guohua Chen Implantable elastomeric caprolactone depot compositions and uses thereof
EP1643968A1 (de) * 2003-05-30 2006-04-12 ALZA Corporation Implantierbare elastomere depot-zusammensetzungen, ihre verwendungen und herstellungsverfahren
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US20080008759A1 (en) * 2006-05-30 2008-01-10 Den-Mat Corporation Method of improving wound healing
GB0613552D0 (en) * 2006-07-07 2006-08-16 Univ Heriot Watt Resorbable insert
CA2738524C (en) * 2008-10-02 2013-11-26 Mylan Inc. Method for making a multilayer adhesive laminate
DE102009022893A1 (de) 2009-05-27 2010-12-02 Bayer Technology Services Gmbh Pulverformulierungen mit Adsorbens-Partikeln
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
US9717660B2 (en) * 2014-02-28 2017-08-01 Regents Of The University Of Minnesota Fluoride releasing dental composition and dental appliance
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN117959489A (zh) * 2016-07-25 2024-05-03 薪创生命科技有限公司 新的骨材料替代合成配方、制备方法和使用方法
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5464630A (en) * 1977-10-31 1979-05-24 Nippon Kayaku Co Ltd Base for film coating
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
IT1213080B (it) * 1986-06-17 1989-12-07 Recordati Chem Pharm Sistemi terapeutico per la cessione controllata di farmaci.
EP0325086A3 (de) * 1987-11-23 1990-10-31 Jago Research Ag Verfahren zur Herstellung von therapeutischen Systemen mit gesteuerter Freigabe des Wirkstoffes
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤

Also Published As

Publication number Publication date
EP0583244B1 (de) 1997-01-08
EP0583244A4 (en) 1994-06-01
WO1992019283A1 (en) 1992-11-12
JPH06507379A (ja) 1994-08-25
DE69124115D1 (de) 1997-02-20
US5085866A (en) 1992-02-04
EP0583244A1 (de) 1994-02-23
DE69124115T2 (de) 1997-07-10
HK1006808A1 (en) 1999-03-19
ES2098495T3 (es) 1997-05-01

Similar Documents

Publication Publication Date Title
ATE147262T1 (de) Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung
PT90153A (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada
ATE73649T1 (de) Mit wirksubstanz beladene biologisch abbaubare substrate, die zur gesteuerten freisetzung der wirksubstanz mit hilfe einer membran geeignet sind.
ATE88887T1 (de) Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung.
ATE18568T1 (de) Herstellung einer hydrophilischen beschichtung.
ATE64850T1 (de) Allgemeines system zur kontrollierten freisetzung eines wirkstoffes nach einer reaktion nullter ordnung.
DE3689896D1 (de) Verfahren zur Herstellung einer wässrigen Polyurethanharnstoffdispersion.
DE69019694D1 (de) Verfahren zur Herstellung einer mehrschichtigen porösen Membran aus Polytetrafluoräthylen.
CA2033277A1 (en) Controlled release pharmaceutical preparation and method for producing the same
DE68923727D1 (de) Verfahren zur Herstellung eines aktiven Matrixsubstrats.
DE59409510D1 (de) Verfahren zur Herstellung einer wässrigen Polymerisatdispersion
DE3868700D1 (de) Verfahren zur herstellung eines optisch aktiven alkohols.
ATE8743T1 (de) Verfahren zur herstellung von strukturen aus lipoiden membranen.
ES2118735T3 (es) Membrana compuesta semipermeable y procedimiento para su fabricacion.
ATE41060T1 (de) Verfahren zur herstellung eines immunreaktiven poroesen traegermaterials.
DE68912734D1 (de) Verfahren zur Herstellung von Tetrafluoräthylen.
ATE46634T1 (de) Schichtelemente, verfahren zu ihrer herstellung sowie ihre verwendung.
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
ATE69795T1 (de) Verfahren zur herstellung von ethylenischen carbonylverbindungen.
DE59004588D1 (de) Verfahren zur Herstellung von Purpurmembran enthaltend Bacteriorhodopsin.
DE69205514D1 (de) Verfahren zur Herstellung einer imprägnierten Kathode.
DE3771381D1 (de) Verfahren zur herstellung von einer waesserigen beschichtungszusammensetzung.
DE68917596D1 (de) VERFAHREN ZUR HYDROFLUORIERUNG VON ALKANEN MIT HILFE DER TaX5-KATALYSATOREN.
BR9206218A (pt) Processo de aplicar cristais de peneira molecular a um suporte, catalisador, e, membrana
DE58901307D1 (de) Verfahren zur herstellung von 4-halo-3-oxo-2-alkoxyiminobuttersaeureestern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties